Do you initiate a GLP-1 receptor agonist as first-line pharmacotherapy ahead of metformin in a patient with newly diagnosed type 2 diabetes and a BMI above 35?
1 Answer
Mednet MemberInvited Expert
Endocrinology · Harvard Medical School
Answered on
Yes
Join for free or sign in to see the full answer